Eisai Co. Ltd.

Pharmaceuticals
Japan
Executive 1Haruo Naito, Chief Executive Officer; | Chief Executive Officer;
Executive 2Hideki Hayashi, Chief Information Officer; | President;
Earnings Per Share Growth (%)12.95%
Cost of Goods Sold (US$ Millions)$1,623
Current Liabilities (US$ Millions)$1,752
Total Assets (US$ Millions)$3,979
Long Term Debt (Millions)N/A
Return on Equity8.26%
Revenue (US$ Millions)$4,605
Total Company Assets$8,832
Revenue Growth (%)-8.96%
Net Income (US$ Millions)$364
Earnings Per Share (US$)$1.27
Total Equity (US$ Millions)$5,018
Profit Margin (%)7.91%
Debt To Equity Ratio (%)N/A
Inventories (Millions)$735